Cyclin‐dependent kinase 9–cyclin K functions in the replication stress response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cyclin‐dependent kinase 9–cyclin K functions in the replication stress response

Published:2010-10-08 Issue:11 Volume:11 Page:876-882
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Rep

Author:

Yu David S¹,Zhao Runxiang²,Hsu Emory L²,Cayer Jennifer¹,Ye Fei³,Guo Yan³,Shyr Yu³,Cortez David²

Affiliation:

1. Departments of Radiation Oncology, Vanderbilt University Medical Center 2215 Garland Avenue Nashville Tennessee 37232 USA

2. Department of Biochemistry, Vanderbilt University Medical Center 2215 Garland Avenue Nashville Tennessee 37232 USA

3. Department of Biostatistics, Vanderbilt University Medical Center 2215 Garland Avenue Nashville Tennessee 37232 USA

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/embor.2010.153

Reference26 articles.

1. Function of a Conserved Checkpoint Recruitment Domain in ATRIP Proteins

2. The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks

3. DNA Damage Response as an Anti-Cancer Barrier: Damage Threshold and the Concept of 'Conditional Haploinsufficiency'

4. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

5. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of specific CDKs in regulating DNA damage repair responses and replication stress;Current Opinion in Pharmacology;2024-12

2. CDK9-55 guides the anaphase-promoting complex/cyclosome (APC/C) in choosing the DNA repair pathway choice;Oncogene;2024-03-04

3. The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study;Cells;2024-02-20

4. SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients;NAR Cancer;2024-01-09

5. Cyclin-dependent kinase 4 and 6 in cancer: Exploration of CDK4/6 inhibitors as anticancer agents;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3